当前位置： SCI文献检索 > ARTHRITIS RESEARCH & THERAPY期刊下所有文献 > Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

Abstract：

:Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening disease of severe hyperinflammation caused by uncontrolled proliferation of activated lymphocytes and macrophages secreting high amounts of inflammatory cytokines. It is a frequent manifestation in patients with predisposing genetic defects, but can occur secondary to various infectious, malignant, and autoimmune triggers in patients without a known genetic predisposition. Clinical hallmarks are prolonged fever, cytopenias, hepatosplenomegaly, and neurological symptoms, but atypical variants presenting with signs of chronic immunodeficiency are increasingly recognized. Impaired secretion of perforin is a key feature in several genetic forms of the disease, but not required for disease pathogenesis. Despite progress in diagnostics and therapy, mortality of patients with severe HLH is still above 40%. Reference treatment is an etoposide-based protocol, but new approaches are currently explored. Key for a favorable prognosis is the rapid identification of an underlying genetic cause, which has been facilitated by recent immunological and genetic advances. In patients with predisposing genetic disease, hematopoietic stem cell transplantation is performed increasingly with reduced intensity conditioning regimes. Current research aims at a better understanding of disease pathogenesis and evaluation of more targeted approaches to therapy, including anti-cytokine antibodies and gene therapy.

journal_name

Arthritis Res Ther

journal_title

Arthritis research & therapy

authors

Bode SF,Lehmberg K,Maul-Pavicic A,Vraetz T,Janka G,Stadt UZ,Ehl S

doi

10.1186/ar3843

subject

Has Abstract

pub_date

2012-06-08 00:00:00

pages

213

issue

3

eissn

1478-6354

issn

1478-6362

pii

ar3843

journal_volume

14

pub_type

杂志文章,评审

相关文献

ARTHRITIS RESEARCH & THERAPY文献大全
  • No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis.

    abstract：INTRODUCTION:The objective was to study the potential genetic contribution of Toll-like receptor (TLR) genes in rheumatoid arthritis (RA). TLRs bind to pathogen-associated molecular patterns, and TLR genes influence both proinflammatory cytokine production and autoimmune responses. Host-pathogen interactions are involv...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar2589

    authors： Jaen O,Petit-Teixeira E,Kirsten H,Ahnert P,Semerano L,Pierlot C,Cornelis F,Boissier MC,Falgarone G,European Consortium on Rheumatoid Arthritis Families.

    更新日期：2009-01-01 00:00:00

  • Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus.

    abstract：BACKGROUND:African Americans with systemic lupus erythematosus (SLE) have increased renal disease compared to Caucasians, but differences in other comorbidities have not been well-described. We used an electronic health record (EHR) technique to test for differences in comorbidities in African Americans compared to Cau...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-018-1561-8

    authors： Barnado A,Carroll RJ,Casey C,Wheless L,Denny JC,Crofford LJ

    更新日期：2018-04-10 00:00:00

  • Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval.

    abstract：:Joint space width (JSW) and narrowing (JSN) measurements on radiographs are currently the best way to assess disease severity or progression in hip osteoarthritis, yet we lack data regarding the most accurate and sensitive measurement technique. This study was conducted to determine the optimal radiograph and number o...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1186/ar1831

    authors： Maheu E,Cadet C,Marty M,Dougados M,Ghabri S,Kerloch I,Mazières B,Spector TD,Vignon E,Lequesne MG

    更新日期：2005-01-01 00:00:00

  • Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic diseas

    abstract：BACKGROUND:Rheumatoid arthritis (RA) patients are treated with a mean of 3-4 conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) with or without glucocorticoids (GCs), before the first biologic prescription. The main reasons for change are inefficacy in 30-40 % of patients, and toxicity ≈ 10 %. Thus...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,多中心研究

    doi：10.1186/s13075-016-1137-4

    authors： Hernández-Cruz B,Márquez-Saavedra E,Caliz-Caliz R,Navarro-Sarabia F

    更新日期：2016-11-08 00:00:00

  • Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disea

    abstract：INTRODUCTION:A higher prevalence of metabolic syndrome (MetS) has been described in rheumatoid arthritis (RA), along with an association with disease activity. Objectives were to describe prevalence of MetS at RA diagnosis in a cohort of Mexican Mestizo early RA patients, and to define a causal association between MetS...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-015-0549-x

    authors： Parra-Salcedo F,Contreras-Yáñez I,Elías-López D,Aguilar-Salinas CA,Pascual-Ramos V

    更新日期：2015-02-20 00:00:00

  • Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.

    abstract：INTRODUCTION:Since current treatment options for patients suffering from active rheumatoid arthritis (RA) remain inadequate, especially for those unresponsive to disease-modifying antirheumatic drugs (DMARDs), new and improved medication is needed. This study evaluates the safety and efficacy of masitinib (AB1010), a p...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1186/ar2740

    authors： Tebib J,Mariette X,Bourgeois P,Flipo RM,Gaudin P,Le Loët X,Gineste P,Guy L,Mansfield CD,Moussy A,Dubreuil P,Hermine O,Sibilia J

    更新日期：2009-01-01 00:00:00

  • Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis.

    abstract：INTRODUCTION:Reconstitution of peripheral blood (PB) B cells after therapeutic depletion with the chimeric anti-CD20 antibody rituximab (RTX) mimics lymphatic ontogeny. In this situation, the repletion kinetics and migratory properties of distinct developmental B-cell stages and their correlation to disease activity mi...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar2686

    authors： Möller B,Aeberli D,Eggli S,Fuhrer M,Vajtai I,Vögelin E,Ziswiler HR,Dahinden CA,Villiger PM

    更新日期：2009-01-01 00:00:00

  • Inflammatory expression profiles in monocyte-to-macrophage differentiation in patients with systemic lupus erythematosus and relationship with atherosclerosis.

    abstract：INTRODUCTION:Our objectives were to examine mononuclear cell gene expression profiles in patients with systemic lupus erythematosus (SLE) and healthy controls and to compare subsets with and without atherosclerosis to determine which genes' expression is related to atherosclerosis in SLE. METHODS:Monocytes were obtain...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar4609

    authors： Korman BD,Huang CC,Skamra C,Wu P,Koessler R,Yao D,Huang QQ,Pearce W,Sutton-Tyrrell K,Kondos G,Edmundowicz D,Pope R,Ramsey-Goldman R

    更新日期：2014-07-10 00:00:00

  • Arhalofenate acid inhibits monosodium urate crystal-induced inflammatory responses through activation of AMP-activated protein kinase (AMPK) signaling.

    abstract：BACKGROUND:Arhalofenate acid, the active acid form of arhalofenate, is a non-agonist peroxisome proliferator-activated receptor γ (PPARγ) ligand, with uricosuric activity via URAT1 inhibition. Phase II studies revealed decreased acute arthritis flares in arhalofenate-treated gout compared with allopurinol alone. Hence,...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-018-1699-4

    authors： McWherter C,Choi YJ,Serrano RL,Mahata SK,Terkeltaub R,Liu-Bryan R

    更新日期：2018-09-06 00:00:00

  • Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.

    abstract：:Reports of the use of HLA-B27/peptide tetrameric complexes to study peptide-specific CD8+ T cells in HLA-B27+-related diseases are rare. To establish HLA-B27 tetramers we first compared the function of HLA-B27 tetramers with HLA-A2 tetramers by using viral epitopes. HLA-B27 and HLA-A2 tetramers loaded with immunodomin...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar1221

    authors： Appel H,Kuon W,Kuhne M,Wu P,Kuhlmann S,Kollnberger S,Thiel A,Bowness P,Sieper J

    更新日期：2004-01-01 00:00:00

  • Reduced pro-inflammatory profile of γδT cells in pregnant patients with rheumatoid arthritis.

    abstract：BACKGROUND:During pregnancy, many patients with rheumatoid arthritis (RA) experience disease improvement, whereas patients with ankylosing spondylitis often suffer from persistent active disease. Here we investigated whether pregnancy-related changes in disease activity were associated with changes in the proportion an...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-016-0925-1

    authors： Tham M,Schlör GR,Yerly D,Mueller C,Surbek D,Villiger PM,Förger F

    更新日期：2016-01-22 00:00:00

  • Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.

    abstract：INTRODUCTION:The non-histone nuclear protein high mobility group box protein-1 (HMGB1) is typically associated with nucleosomes, but may shuttle between the nucleus and the cytoplasm, and under some conditions also be released extracellularly and participate in systemic inflammation. Monoclonal HMGB1-targeting antibodi...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-015-0856-2

    authors： Wirestam L,Schierbeck H,Skogh T,Gunnarsson I,Ottosson L,Erlandsson-Harris H,Wetterö J,Sjöwall C

    更新日期：2015-11-23 00:00:00

  • Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes.

    abstract：INTRODUCTION:Osteoclastogenesis plays an important role in the bone erosion of rheumatoid arthritis (RA). Recently, Notch receptors have been implicated in the development of osteoclasts. However, the responsible Notch ligands have not been identified yet. This study was undertaken to determine the role of individual N...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3758

    authors： Sekine C,Koyanagi A,Koyama N,Hozumi K,Chiba S,Yagita H

    更新日期：2012-03-05 00:00:00

  • Potential role of IFNα in adult lupus.

    abstract：:Patients with lupus have a continuous production of IFNα and display an increased expression of IFNα-regulated genes. The reason for the ongoing IFNα synthesis in these patients seems to be an activation of plasmacytoid dendritic cells (pDCs) by immune complexes (ICs), consisting of autoantibodies in combination with ...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar2884

    authors： Rönnblom L

    更新日期：2010-01-01 00:00:00

  • Osteopontin - a biomarker for organ damage in paediatric lupus?

    abstract：:A growing body of literature has demonstrated that the multifunctional glycoprotein osteopontin (OPN), has a role in type I interferon (IFN) production and may be involved in systemic lupus erythematosus (SLE) pathogenesis. A recent report has provided further support for this, demonstrating an association between rai...

    journal_title：Arthritis research & therapy

    pub_type： 评论,社论

    doi：10.1186/ar4172

    authors： Briggs TA

    更新日期：2013-03-08 00:00:00

  • Expanding the armamentarium for the spondyloarthropathies.

    abstract：:Ankylosing spondylitis (AS) is a member of the family of spondyloarthropathies, which are inflammatory arthritides largely involving the axial skeleton and commonly accompanied by peripheral arthritis. Genetic factors, particularly the presence of HLA-B27, are major contributors to the susceptibility for AS. Despite s...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar1012

    authors： Peloso PM,Braun J

    更新日期：2004-01-01 00:00:00

  • Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).

    abstract：INTRODUCTION:The present study aimed to explore a possible role for IL-21 producing Th-cells in the immunopathogenesis of granulomatosis with polyangiitis (GPA). METHODS:Peripheral blood from 42 GPA patients in remission and 29 age-matched healthy controls (HCs) were stimulated in vitro, and the frequencies of IL-21 p...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar4247

    authors： Abdulahad WH,Lepse N,Stegeman CA,Huitema MG,Doornbos-van der Meer B,Tadema H,Rutgers A,Limburg PC,Kallenberg CG,Heeringa P

    更新日期：2013-01-01 00:00:00

  • Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome.

    abstract：:Genetic and environmental factors may play a role in the etiopathology of fibromyalgia syndrome (FMS) and other related syndromes. There is a high aggregation of FMS in families of FMS patients. The mode of inheritance is unknown but it is most probably polygenic. There is evidence that polymorphisms of genes in the s...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar2005

    authors： Buskila D,Sarzi-Puttini P

    更新日期：2006-01-01 00:00:00

  • Validating English- and Spanish-language patient-reported outcome measures in underserved patients with rheumatic disease.

    abstract：INTRODUCTION:Rheumatic diseases are among the most common and debilitating health problems in the United States. These diseases are chronic, can result in severe decrements of physical and psychosocial functioning and affect patients' overall quality of life. A consensus regarding the best patient outcomes to be measur...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3219

    authors： Wallen GR,Middleton KR,Rivera-Goba MV,Mittleman BB

    更新日期：2011-01-05 00:00:00

  • AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases.

    abstract：OBJECTIVE:To assess the associations between aspartate transaminase/alanine transaminase ratio (DRR) and mortality in patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD). PATIENTS AND METHODS:This was a retrospective cohort study, which included 522 patients with PM/DM-ILD whose...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-020-02286-w

    authors： Li R,Zhu WJ,Wang F,Tang X,Luo F

    更新日期：2020-09-20 00:00:00

  • New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis.

    abstract：:Recent genome-wide association studies have implicated the tumor necrosis factor receptor-associated factor 3-interacting protein 2 (TRAF3IP2) gene and its product, nuclear factor-kappa-B activator 1 (Act1), in the development of psoriatic arthritis (PsA). The high level of sequence homology of the TRAF3IP2 (Act1) gen...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar4071

    authors： Doyle MS,Collins ES,FitzGerald OM,Pennington SR

    更新日期：2012-10-31 00:00:00

  • Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.

    abstract：INTRODUCTION:We and others have previously shown that antibodies against cyclic citrullinated proteins (anti-CCP) precede the development of rheumatoid arthritis (RA) and in a more recent study we reported that individuals who subsequently developed RA had increased concentrations of several cytokines and chemokines ye...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3237

    authors： Kokkonen H,Mullazehi M,Berglin E,Hallmans G,Wadell G,Rönnelid J,Rantapää-Dahlqvist S

    更新日期：2011-02-03 00:00:00

  • A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial.

    abstract：BACKGROUND:Comorbidities may contribute to disease activity and treatment response in rheumatoid arthritis (RA) patients. We defined a somatization comorbidity phenotype (SCP) and examined its influence on response to certolizumab pegol (CZP) using data from the PREDICT trial. METHODS:Patients in PREDICT were randomiz...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.1186/s13075-017-1412-z

    authors： Curtis JR,Herrem C,Ndlovu 'N,O'Brien C,Yazici Y

    更新日期：2017-09-29 00:00:00

  • Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis.

    abstract：INTRODUCTION:Rational selection of disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis (RA) has many potential advantages, including rapid disease control, reduced long-term disability and reduced overall cost to the healthcare system. Inter-individual genetic differences are particularly at...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3911

    authors： Wiese MD,Schnabl M,O'Doherty C,Spargo LD,Sorich MJ,Cleland LG,Proudman SM

    更新日期：2012-07-12 00:00:00

  • Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

    abstract：INTRODUCTION:Progressive fibrosis in systemic sclerosis (SSc) is linked to aberrant transforming growth factor beta (TGF-beta) signaling. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) blocks fibrogenic TGF-beta responses in vitro and in vivo. Reduced expression and function of PPAR-gamma in patients wit...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3827

    authors： Lakota K,Wei J,Carns M,Hinchcliff M,Lee J,Whitfield ML,Sodin-Semrl S,Varga J

    更新日期：2012-05-01 00:00:00

  • Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.

    abstract：BACKGROUND:The presence of autoantibodies is considered an important characteristic of rheumatoid arthritis (RA); therefore, both anticitrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are included in the 2010 classification criteria for rheumatoid arthritis (RA). However, a considerable number of RA pa...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-018-1591-2

    authors： Boeters DM,Trouw LA,van der Helm-van Mil AHM,van Steenbergen HW

    更新日期：2018-05-03 00:00:00

  • Developments in the clinical understanding of rheumatoid arthritis.

    abstract：:The changes occurring in the field of rheumatoid arthritis (RA) over the past decade or two have encompassed new therapies and, in particular, a new look at the clinical characteristics of the disease in the context of therapeutic improvements. It has been shown that composite disease activity indices have special mer...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar2535

    authors： Smolen JS,Aletaha D

    更新日期：2009-01-01 00:00:00

  • Abnormalities of T cell signaling in systemic lupus erythematosus.

    abstract：:Systemic lupus erythematosus (SLE) is an autoimmune disease resulting from a loss of tolerance to multiple self antigens, and characterized by autoantibody production and inflammatory cell infiltration in target organs, such as the kidneys and brain. T cells are critical players in SLE pathophysiology as they regulate...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章,评审

    doi：10.1186/ar3251

    authors： Moulton VR,Tsokos GC

    更新日期：2011-03-17 00:00:00

  • Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.

    abstract：BACKGROUND:Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are chronic inflammatory rheumatic diseases with complex origins. Both are characterized by altered extracellular matrix remodeling in joints and entheses that results in destructive and osteochondral proliferative lesions. There is a need for bio...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/s13075-016-1040-z

    authors： Gudmann NS,Munk HL,Christensen AF,Ejstrup L,Sørensen GL,Loft AG,Karsdal MA,Bay-Jensen AC,He Y,Siebuhr AS,Junker P

    更新日期：2016-06-16 00:00:00

  • Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells.

    abstract：INTRODUCTION:To date, no single most-appropriate factor or delivery method has been identified for the purpose of mesenchymal stem cell (MSC)-based treatment of cartilage injury. Therefore, in this study we tested whether gene delivery of the growth factor Indian hedgehog (IHH) was able to induce chondrogenesis in huma...

    journal_title：Arthritis research & therapy

    pub_type： 杂志文章

    doi：10.1186/ar3921

    authors： Steinert AF,Weissenberger M,Kunz M,Gilbert F,Ghivizzani SC,Göbel S,Jakob F,Nöth U,Rudert M

    更新日期：2012-07-20 00:00:00